Pantoprazole Pellets
Multi-strength pantoprazole pellets for erosive esophagitis and GERD therapies, demonstrating low ash content for clean processing.
Pantoprazole Pellets - pharmaceutical overview
Pantoprazole pellets from Rraynex underpin a broad portfolio of proton pump inhibitor therapies that call for multiple strengths. Manufacturing starts with pharmacopeial pantoprazole sodium sesquihydrate processed in humidity-controlled suites. Seal coats, drug layering, and enteric polymers are carefully sequenced to protect the acid-labile core while delivering low ash content for downstream compression. Pellets exhibit consistent size distribution, supporting MUPS tablets, capsules, or sachet formulations without segregation. Quality monitoring covers assay, moisture, and dissolution across strengths to maintain predictable gastric resistance. We supply detailed technical information encompassing dissolution comparisons, impurity trend analyses, and stability data aligned to ICH zones. Packaging is flexible, with moisture-barrier drums, foil-lined bags, and pilot-scale packs available to match forecast demand. Technical teams assist with method transfers, lubricant selection, and compatibility evaluations with excipients such as MCC, crospovidone, or mannitol. Regulatory specialists maintain ready-to-file CTD modules and transparent change-control logs, allowing customers to launch or scale pantoprazole products efficiently.
Pantoprazole Pellets formulation considerations
- Controlled pelletization and coating for reproducible dissolution and downstream handling.
- Uniform particle size and morphology suitable for capsule filling and multiparticulate systems.
- Manufactured under WHO-GMP with in-process controls on assay, moisture and related substances.
- Technical support for formulation development, scale-up and regulatory documentation.
Technical specifications are available upon request.
Applications
- Capsule filling and multiparticulate dosage forms (including MUPS where applicable).
- Pharmaceutical formulation and commercial manufacturing for Anti-Ulcerant (Ppls) therapies.
- CDMO and contract manufacturing programs requiring bulk pantoprazole pellets.
Bulk pharmaceutical supply & commercial manufacture
Rraynex operates as a pharmaceutical pellets manufacturer and supplier based in India, supporting bulk supply, export and contract manufacturing for Pantoprazole Pellets. Supply is available in standard 25/50 kg packaging with batch traceability. Export documentation, DMF/COA access procedures and stability information are provided on request for applicable products.
Contact Rraynex for bulk pellet supply • View manufacturing capabilities
Bulk pharmaceutical supply & product enquiries
Looking to source Pantoprazole Pellets in bulk? Rraynex supports pharmaceutical companies seeking Pantoprazole Pellets for formulation development, capsule filling and commercial pharmaceutical manufacturing. Buyers can request product specifications, available strengths, technical documentation, samples where applicable, commercial quotations and bulk supply information.
- product specifications
- available strengths
- technical documentation
- samples where applicable
- commercial quotations
- bulk supply information
B2B supply only — not a consumer pharmacy. Pricing available on request for bulk quantities.
Related capabilities
Related products
Technical specifications
- Grade
- IP / BP / USP / EP
- Type
- Pellets
- Category
- Anti-Ulcerant (Ppls)
- Pack size
- 25/50 kg
- Available strengths
- 8.5%, 15%, 20%, 22.5%, 25%, 30%
- Certifications
- WHO-GMP, ISO 9001, ISO 14001
Only use specification terms supported by existing product data. Additional technical documentation is available upon request.